Search clinical trials for: Expectorants

Total 619 results

Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis

Bronchiectasis Adult
Azidus Brasil

Unknown

Effectiveness and Safety of the of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improvement of Symptoms Resulting From Acute Respiratory Infections.

Upper Airway Infections

Brazil
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.

Bronchitis

China
Liaocheng People's Hospital

Unknown

Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension

China
Boehringer Ingelheim

Completed

Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat

Pharyngitis

China
Edmond Pharma

Unknown

The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD) (RESTORE)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium, Bulgaria, Czech Republic, Denmark, France, Italy, Poland, Romania, Slovakia, United Kingdom
Helse Fonna
Helse-Bergen HF; Klinbeforsk

Recruiting

Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial (ANeED)

Dementia With Lewy Bodies

Norway
Agyany Pharma LTD

Recruiting

High-Dose Ambroxol in GBA1-Related Parkinson

Parkinson Disease | GBA Gene Mutation

Israel
Hyundai Pharmaceutical Co., LTD.

Completed

Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis

Acute Bronchitis
Exsar Corporation

Suspended

Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease

Type I Gaucher Disease

United States
Adams Respiratory Therapeutics

Completed

Phase 2 Study - Erdosteine in Patients With CB/COPD

Chronic Obstructive Pulmonary Disease | Chronic Bronchitis

United States
Federal State Budgetary Institution, V. A. Almazov...

Completed

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

Increased Risk of SARS-CoV-2 Infection

Russian Federation
University College, London
The Cure Parkinson's Trust

Completed

Ambroxol in Disease Modification in Parkinson Disease (AiM-PD)

Parkinson Disease

United Kingdom
Lawson Health Research Institute
Western University, Canada; London Health Sciences Centre; Weston Brain Institute

Active, not recruiting

Ambroxol as a Treatment for Parkinson's Disease Dementia

Parkinson's Disease Dementia

Canada
Sanofi

Completed

Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis (DELICIOUS)

Pharyngitis

South Africa
Boehringer Ingelheim

Completed

Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis

Pharyngitis

South Africa
Second Affiliated Hospital of Wenzhou Medical University
Wanbangde Pharmaceutical Group Co., LTD

Not yet recruiting

Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults

Pharmacokinetics
Boehringer Ingelheim

Completed

Ambroxol Spray Sore Throat Study

Pain | Pharyngitis

South Africa
Hull University Teaching Hospitals NHS Trust
Galen Limited

Withdrawn

Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
University Medical Center Groningen

Recruiting

GRoningen Early-PD Ambroxol Treatment (GREAT)

Parkinson Disease | Parkinson

Netherlands
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...
University of Campania "Luigi Vanvitelli"; IRCCS National Neurological Institute...

Active, not recruiting

Ambroxol as a Disease-modifying Treatment in GBA-PD (AMBITIOUS)

Parkinson Disease | GBA Gene Mutation

Italy
Lawson Health Research Institute

Not yet recruiting

Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia

Lewy Body Disease

Canada
Shaare Zedek Medical Center

Completed

Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy

Gaucher Disease, Type 1

Israel
University College, London

Not yet recruiting

Ambroxol to Slow Progression in Parkinson Disease (ASPro-PD)

Parkinson Disease

United Kingdom
Hull University Teaching Hospitals NHS Trust
Sanofi

Completed

A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough.

Cough

United Kingdom
Massachusetts Eye and Ear Infirmary

Completed

Mucinex® for Treatment of Filamentary Keratitis

Filamentary Keratitis

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of Ambroxol Lozenges in Healthy Male Volunteers

Healthy
Hallym University Kangnam Sacred Heart Hospital

Completed

Effects of Oral Mucolytics on Tear Film and Ocular Surface

In the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.

Korea, Republic of
Royal North Shore Hospital

Unknown

Citriodiol® and Impetigo

Impetigo

Australia
Boehringer Ingelheim

Completed

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

Healthy
Reckitt Benckiser Inc.

Completed

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

Healthy Subjects
Reckitt Benckiser LLC

Completed

Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

Healthy Subjects
Reckitt Benckiser LLC

Completed

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

Healthy Subjects
Ain Shams University

Not yet recruiting

Effect of Ambroxol in Diabetic Peripheral Neuropathy

Diabetic Neuropathy Peripheral

Egypt
National University of Malaysia

Completed

Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients

Critical Illness | Hospital-acquired Pneumonia | Community-acquired Pneumonia | Severe Pneumonia

Malaysia
Reckitt Benckiser Inc.

Completed

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Healthy Subjects
The Florey Institute of Neuroscience and Mental...
The University of Queensland; Mobius Medical Pty Ltd.

Recruiting

A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS (AMBALS)

Amyotrophic Lateral Sclerosis

Australia
Boehringer Ingelheim

Completed

Relative Bioavailability of Ambroxol Hydrochloride of Soft Pastilles Compared to Ambroxol Hydrochloride Syrup in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics and Bioavailability Study of Lasolvan Hard Capsules and Effervescent Tablets in Healthy Volunteers

Healthy

Russian Federation
Hanmi Pharmaceutical Company Limited

Completed

A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male Volunteers

Healthy
Kantonsspital Baselland Bruderholz

Completed

Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural

Healthy

Switzerland
Reckitt Benckiser LLC

Completed

Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion

Healthy Subjects
Weill Medical College of Cornell University

Completed

The Effects of Potassium Citrate on Bone Metabolism

Bone Diseases, Metabolic | Osteoporosis, Postmenopausal

United States
European Georges Pompidou Hospital
Institut National de la Santé Et de la Recherche Médicale, France; Sponsor...

Completed

Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria

Glomerulonephritis | Cystinuria | Renal Lithiasis | Interstitial Nephritis

France
Albert Einstein College of Medicine
Columbia University; University of Utah; University of Pittsburgh Medical Center

Recruiting

Bone in CKD Alkali Response (BICARb Pilot Trial) (BICARb)

Chronic Kidney Diseases | Bone Loss

United States
Erasmus Medical Center
University Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaborators

Recruiting

Potassium Supplementation in CKD (K+ in CKD)

Hypertension | Renal Insufficiency, Chronic | Hyperkalemia | Potassium Depletion

Netherlands
Juan A. Arnaiz

Unknown

Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature (PRENECAL)

Nephrocalcinosis

Spain
Belfast Health and Social Care Trust
Queen's University, Belfast

Recruiting

Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR) (CLEAR)

Bronchiectasis

United Kingdom

Search clinical trials for: Expectorants

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations